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Objectives: Osteoarthritis (OA) is the most common arthropathy of the hand, and current 
treatments carry risks of adverse events. Supportive (kinesiology) tape may be analgesic and 
provide functional improvement, with a low risk of adverse outcomes. We experimented with 
supportive tape for OA of the proximal interphalangeal joint (PIPJ) of the finger in this pilot 
randomized trial.
Methods: This two-group parallel randomized trial recruited adults with OA of the PIPJ of the 
finger. We excluded patients lacking capacity or the ability to safely apply the tape. Participants 
were randomized to receive kinesiology tape on the dorsum of the finger, blind to grouping. Pain 
was the primary outcome, which was recorded on a visual analog scale (VAS). Secondary outcomes 
were hand function and adverse reactions. Bootstrapped between-group analyses are reported. 
Results: Ten patients were included and randomized and provided complete data. There was 
no significant difference in pain between the groups (mean difference of 0.4 VAS units [95% 
confidence interval {CI} –1.6, 0.7], p=0.4). Overall, the application of kinesiology tape reduced 
reported pain by 6% (mean reduction of 0.6 VAS units [95% CI 0, 1.2], p=0.04). Taping did not 
affect hand function or digital range of motion. There were difficulties in recruiting individuals 
owing to the lack of dedicated research staff. 
Conclusion: Kinesiology taping may reduce the pain of OA in the finger; however, whether 
this is a true effect, placebo effect, Hawthorne phenomenon, or due to a statistical error (ie, type 
1 error due to underpowering) is unclear. Hence, further trials are required. 
Keywords: osteoarthritis, hand, kinesiology, tape, pain, trial, pilot, randomized, PIPJ, proximal 
interphalangeal joint, digit
Introduction
Osteoarthritis (OA) of the hand is the most common arthropathy worldwide, with a 
symptomatic prevalence of 67%.1 After the basal thumb joint, the interphalangeal 
joints (IPJs) of the hand are most commonly affected.2,3 In the UK, 1.9 million people 
per annum seek medical attention for OA in their hands.3 
Most patients with OA of the hand require simple analgesia only, although the 
treatment options are globally limited by poor quality evidence showing marginal 
benefit. Topical nonsteroid anti-inflammatory drugs benefit a minority of patients but 
carry the risk of skin reactions.4 Intra-articular injections (eg, corticosteroids, local 
anesthetics, or hyaluronic acids) are used but lack evidence of a sustained benefit in 
OA of the basal thumb joint5 or IPJs of the hand.6 Ultimately, some patients require 
arthrodesis or arthroplasty, but again, the effectiveness of these operations remains 
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controversial because the evidence is of poor quality and 
lacks patient-reported outcomes, and 28% experience com-
plications.7 A systematic review by Bertozzi et al showed 
little evidence of a sustained reduction in OA pain from 
traditional hand therapies,8 including no significant reduc-
tion in pain from advice, static splints, or laser therapy; the 
combination of therapeutic exercises and manual therapies 
conferred moderate-quality evidence of a small reduction in 
pain; magnetotherapy examined in one trial found moder-
ate evidence of a reduction in pain from basal thumb OA. 
Similarly, Østerås et al showed a small beneficial effect of 
exercise on hand pain (5% reduction, low-quality evidence), 
hand function, and finger joint stiffness, but these findings 
were unlikely to represent a clinically important change.9 
Therefore, there is a pressing need for simple and low-risk 
sustained analgesia for symptomatic OA of the hand.
Commercially available kinesiology tapes are widely 
used, and numerous reviews demonstrate their analgesic 
effect in various musculoskeletal disorders.10–13 The theory 
underpinning kinesiology tape is that tension applied along 
the tape (which alters with movement) stimulates mechano-
receptors in the skin, reducing nociception and thus “clos-
ing the gate” to pain.14,15 While there are no commercially 
available products for the fingers, the Suture Strip® Plus 
marketed by Dermasciences (Ontario, Canada) has similar 
properties. Suture Strip® Plus is made from a waterproof 
microporous non-woven webbed polyamide/polyester with 
pressure-sensitive polyacrylate adhesive, which may provide 
a similar analgesic effect to other kinesiology tapes on a scale 
applicable to the hand. 
The aim of this study was to investigate the perceived 
benefits of Suture Strip® Plus tape, applied to dorsum of 
the proximal interphalangeal joint (PIPJ), in patients with 
established OA. We hypothesized that taping will 1) reduce 
perceived pain in accordance with the gate theory but also 
2) not limit the active range of motion (aROM) of the PIPJ.
Materials and methods 
The protocol for this trial is available at www.clinicaltrials.
gov (NCT02220374). The study was approved by both The 
Mid Yorkshire Hospitals NHS Trust (Reference 14/927) 
and the National Research Ethics Service (Reference 14/
YH/1040). The manuscript has been authored in accordance 
with the CONSORT statement.16,17
Design
This is a pilot pragmatic blocked two-group parallel random-
ized trial.
Research questions
Primary research question
1. Does taping the dorsum of the PIPJ of the finger affect 
reported pain?
Secondary research questions
1. Does taping the dorsum of the PIPJ of the finger confer 
adverse reactions?
2. Does taping the dorsum of the PIPJ of the finger affect 
reported or objective hand function?
Participants
We included adults (aged ≥18 years) attending the plastic 
surgery outpatient department or hand therapy unit in the 
host institution, with an established diagnosis of chronic 
OA of the PIPJ of any finger based on both symptoms and 
radiographic changes. We excluded patients meeting any of 
the below criteria, as judged by CP/NH:
•	 Non-English speakers – this pilot trial was unfunded, so 
interpreter costs could not be met.
•	 Those unable to consent or lacking capacity (unable to 
understand, retain, weigh up or communicate their deci-
sion) for any reason.
•	 Those (patients or carers) who lacked the dexterity to cut 
and apply the tape to the painful finger.
•	 Those with an active infection or an unhealed wound on 
the same hand, as this may confound the outcome.
•	 Dermatological conditions involving the proposed trial 
finger, as this may confound the outcome and make tape 
application impractical. 
•	 Vulnerable or thin dorsal skin on the proposed trial finger 
which may torn by the removal of the tape. This was a 
concern of the ethics committee despite no published 
reports of lacerations from the removal of such dressings.
Participants were instructed to continue their usual medi-
cation and not introduce any new non-pharmacological or 
medical therapies for their OA between recruitment and study 
completion. No participant underwent any medical interven-
tion (eg, injection or surgery) during the study period. This 
trial gained approval from the South Yorkshire Committee 
from the National Research Ethics Service (Reference 14/
YH/1040). Written informed consent was provided by all 
the participants.
Intervention
The trial was conducted over 3 weeks, with three distinct 
phases. During week 1 no tape was applied; week 2 was the 
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experimental week and participants applied the tape daily; 
week three was the washout period when no tape was applied.
Both the groups were taught to apply ¼ inch Suture 
Strip® Plus tape to the dorsum of the symptomatic PIPJ 
during week 2. Participants in the intervention group were 
taught to apply the Suture Strip® Plus tape in the configura-
tion which is hypothesized to be supportive and so carry 
analgesic potential for the PIPJ (Figure 1). This configuration 
was based upon the theory and application instructions for 
kinesiology products (application inline with the action of 
underlying muscles/tendons, to stimulate cutaneous stretch 
receptors, so that at the PIPJ, this would be parallel to the 
extensor tendon). Participants were given face-to-face train-
ing by CP/NH and a step-by-step photographic guide of how 
to measure the lengths of Suture Strip® Plus tape required 
(mid-point of the metacarpophalangeal joint-PIPJ to midpoint 
of the PIPJ-distal interphalangeal joint) and apply them over 
the symptomatic PIPJ, in an elliptical configuration, with 
the extremities of the tape overlapping. In comparison, the 
control group were taught to apply the tape in a configuration 
hypothesized to deliver no analgesic effect (ie, be a placebo) 
over the dorsum of the PIPJ (parallel to the articular surfaces 
of the PIPJ, with one strip proximal and one distal) as shown 
in Figure 2. Participants were instructed to apply the tape 
every day during week 2 and retain it for as much as the day 
as possible (eg, apply it first thing in the morning and remove 
it at night). If the tape fell off, became wet, or tore, then 
participants were instructed to replace the tape. We applied 
the tape during the day, so that the analgesic benefit could 
be realized and functional impairment (if any) quantified.
Outcomes
The primary outcome measure was change in reported pain 
between the groups over time. Pain was reported daily over 
the 3-week trial period using a paper-based 100 mm visual 
analog scale (VAS) without intervals. The VAS was a straight 
line with “no pain” at one end and “worst imaginable pain” 
at the other. A VAS was chosen because participants could 
accurately record their pain perceptions without limitation 
(eg, by a Likert system) and measurement differences of 1% 
may be captured. Participants were given the paper VASs and 
asked to complete one per day, at the same time each day.
To investigate our secondary outcomes of interest, par-
ticipants completed a QuickDASH18 on the 7th, 14th, and 
21st day of the trial (the end of each week); patients were 
given all three and asked to complete one at the end of each 
week. This validated patient-reported outcome measure of 
upper limb function provided a functional assessment at 
each phase. Participants were telephoned weekly to enquire 
about adverse events/reactions. At the end of the trial, we 
provided participants with the opportunity to share their 
thoughts (written or verbally) of the tape, how it integrated 
with their day-to-day life, and how we may improve the 
treatment. aROM was measured by using a Roylan finger 
A B C
D E F
Figure 1 The upper row of photographs (A–C) show the configuration of tape hypothesized to provide a benefit and so applied to participants in the intervention group. 
The lower row of photographs (D–F) shows the hypothesized placebo configuration used in the control group.
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goniometer (Patterson Medical) in degrees by CP/NH in the 
affected digit, both with and without tape, at baseline and 
at the end of the trial.
Sample size
There are no published data on which to base a power calcu-
lation. We estimated a clinically relevant difference in pain 
between groups to be 10% (10 mm). Therefore, assuming 
equal standard deviations of 10%, we required 32 subjects 
(16 per group) for 80% power at a 5% significance level. 
We planned for a 50% rate of enrolment and 20% attrition 
and hence originally planned our recruitment to last for 6 
months. However, the recruitment proved difficult, and this 
pilot trial was extended for 8 months, but still we failed 
to recruit the required sample size; these difficulties are 
discussed.
Randomization, allocation and blinding
Participants were randomized 1:1 according to a random 
number table, with random block sizes of 4 and 6. Group 
allocations (as Group 1 or Group 2) were concealed in 
sequentially numbered, sealed opaque envelopes. There was 
no stratification. Consenting participants were randomized 
by an independent third party (the receptionist of the Hand 
Therapy Department). Envelopes were drawn in turn and 
opened, and the group allocation was recorded in a dedi-
cated research diary. Thereafter, the allocation (Group 1 or 
2) was conveyed to the therapist (CP/NH) in the absence of 
the participants. 
The hand therapist (CP/NH) could not be blind to group-
ing because they were teaching the taping method to the 
participants and were involved in the trial conception, design, 
and planning. However, which method of taping is effective 
(if either are effective at all) is uncertain, and hence, the 
opportunity for bias is debatable. The participants were blind 
to grouping as their documentation read “Group 1” or “Group 
2”, and they were not privy to the hypothesized beneficial 
configuration of tape. There is no prior research on this topic 
which participants could use to subvert the blinding. Both 
the therapists were taught how to apply the tape and conduct 
the trial in an identical manner.
Statistical analyses
Anonymous outcome data were provided to RGW at the 
conclusion of the trial. Groups were decoded from Group 
1 to Control and Group 2 to Intervention, and data were 
analyzed unblinded. Pain was analyzed by normal methods 
because the measures of centrality were similar; histograms 
15 assessed for eligibility
4 excluded in total:
2 declined;
1 due to a language barrier;
1 due to cognitive impairment
11 randomized
6 allocated to and received
the intervention taping
1 discontinued as taping
interfered with her
occupation as a nurse
5 analyzed 5 analyzed
5 allocated to and received
the control taping
0 discontinued
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Figure 2 A flow diagram of participant inclusion.
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Figure 3 A plot showing mean reported pain between groups (with 95% CI). The intervention group is shown as a red star, the control group as a green dot.  
Abbreviations: CI, confidence interval; VAS, visual analog scale.
approximated the normal and between-group differences 
with 95% confidence intervals (CI) could be generated. 
Between-group and within-group changes in pain and range 
of motion were analyzed by linear regression. To improve 
the accuracy and thus the external validity of confidence 
intervals for our estimates, we used lossless nonparametric 
bootstrapping by resampling by replacement with 1,000 
iterations.19 Quick-DASH outcomes are strongly skewed and 
so presented as medians with interquartile ranges (IQRs) 
and compared with the Mann–Whitney U-test. Changes in 
Quick-DASH scores were analyzed by using Friedman’s 
two-way analysis of variance by ranks. Categorical variables 
are presented as frequencies (with percentages) and com-
pared with Fisher’s exact test. Analyses were planned on an 
intention-to-treat (ITT) basis. Significance was set at p<0.05. 
Results
Figure 2 demonstrates the participant inclusion in this 
study. One female was randomized but dropped out 
before any outcome data could be recoded; hence, ITT 
was impossible. 
The mean age of participants was 62.4 years (SD 8.4). 
There were three males and two females in the control 
group, and five females in the intervention group (p=0.4). 
Seven were right-handed with no between-group difference 
(p=0.5). Hand dominance was not associated with laterality 
of the trial digit (p=0.5). There were three smokers (one in 
the control group). Five participants were working. The use 
of regular oral analgesia was balanced.
There was no significant difference in the change in pain 
between group, from baseline to week 1 (mean reduction 
of 0.5 VAS units [95% CI –1.7, 0.8], p=0.9). For the whole 
sample, the application of kinesiology tape reduced reported 
pain by 6% (mean reduction of 0.6 VAS units between weeks 
1 and 2 [95% CI 0, 1.2], p=0.04), although there was no 
between-group difference (mean difference of 0.4 VAS units 
[95% CI –1.6, 0.7], p=0.4). After the washout period, the 
analgesic effect of taping persisted to week 3 as there was 
no change in VAS pain scores compared to week 2 (95% 
CI –0.3, 0.6) or baseline (95% CI –1.6, 0.1), but again, 
there were no between-group differences (p=0.1). Figure 3 
summarizes pain scores over the trial period. 
Quick-DASH scores were not affected by taping (Table 1). 
For the intervention group, there was no significant change 
in the Quick-DASH general scores (p=0.6) or work module 
scores (p=0.4). Similarly, for the control group, there was no 
significant change in quick-DASH general scores (p=0.1) or 
work module scores (p=0.9).
Taping did not affect the range of motion in any finger 
joint (Table 2). At baseline, taping did not change the total 
aROM for the sample overall (95% CI of change –63, 19°) or 
per group (p=0.4). No issues were reported by seven patients. 
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Negative feedback was provided by three participants, and 
one participant dropped out, which are described below:
•	 Two 72-year-old participants, one male (placebo group) 
and one female (intervention group) stated that they 
“perceived no benefit”. The male reported a “flare of OA 
in week three”, which he attributed to the tape.
•	 54-year-old female working in catering (intervention 
group) – “occasionally had to remove the tape as it felt 
uncomfortable”. This was qualified with a verbal expla-
nation that sometimes it felt too tight, particularly when 
bending the finger.
•	 52-year-old health care worker (randomized to the 
intervention group) – this participant dropped out after 
randomization and provided no outcome data. She was 
telephoned once recruitment had concluded to enquire 
about her experience, and she reported that once she had 
seen the tape applied and tried it at home; she felt that 
it was incompatible with her occupation as a health care 
professional.
Discussion
All available treatments for OA of the hand carry risks of 
adverse reactions and offer modest benefits, based upon low/
moderate quality evidence. Therefore, we sought to inves-
tigate a novel and low-risk simple analgesic to supplement 
the array of management options. 
We have shown a potential analgesic effect of taping, 
which warrants further investigation. Our pilot trial data 
suggest that taping in either orientation reduces pain by ~6% 
(95% CI 0%, 12%). Although we found no between-group 
differences (ie, the primary outcome), this effect is interesting 
and potentially clinically important because most medical and 
surgical interventions aimed at relieving pain from OA of the 
hand offer minimal reductions in pain (if any),4,6,8 at the cost 
of potentially seriously complications. More importantly, the 
expected reduction in pain could be as great as 12% or nil; 
the lower limit of this confidence suggests that taping does 
not make patients worse, which means that kinesiology tap-
ing could be trialed with little risk of harm. However, there 
was one episode of symptom flare and whether this is part 
of the natural history of the disease or an adverse reaction 
remains unclear. We observed no stiffness post-taping which 
is advantageous as splint-based therapies and surgery usually 
result in stiffness; whether there is truly no stiffness with 
taping or we have failed to detect it is still unclear. Further-
more, we observed a short-term persistent analgesic effect 
from taping which endured beyond the removal of the tape. 
Overall, whether any observed changes in the measured out-
comes are due to a Hawthorne, placebo, or true effect cannot 
be ascertained from this study, and a definitive randomized 
trial is now warranted. This would ideally be designed as 
Table 1 Primary and secondary outcomes
Placebo Time 
point
Group Mean difference 
(95% CI)
p-value
Placebo Intervention
Mean reported pain on VAS (SD) Pre-Tape 4.6 (2.9) 5.5 (2.6) 0.9 (–2.4, 4.2) 0.6*
Taped 4.3 (2.6) 4.7 (2.9) 0.4 (2.9, 3.8) 0.8*
Post-Tape 4.5 (2.0) 4.2 (3.1) –0.3, (–3.3, 2.8) 0.9*
Median Quick-DASH (IQR) Pre-Tape 53.1 (50, 56.3) 31.3 (25, 62.5) n/a 0.1¥
Taped 21.6 (13.6, 29.5) 50 (36.4, 54.5) n/a 0.1¥
Post-Tape 27.3 (17, 38.6) 47.2 (36.4, 63.9) n/a 0.3¥
Median Quick-DASH work module (IQR) Pre-Tape 53.1 (50, 56.3) 31.3 (25, 62.5) n/a 0.8¥
Taped 50 (50, 50) 25 (18.8, 56.3) n/a 0.8¥
Post-Tape 27.3 (17.1, 38.6) 47.2 (36.4, 63.9) n/a 0.7¥
Notes: *Derived from linear regression, with lossless nonparametric bootstrapping by resampling by replacement with 1,000 iterations. ¥Derived from Mann–Whitney 
U-tests. A higher Quick-DASH score indicates greater disability.
Abbreviations: CI, confidence interval; IQR, interquartile range; n/a, not applicable; SD, standard deviation.
Table 2 Change in aROM
Group Joint Mean total aROM in 
degrees (SD) without 
tape applied
Absolute 
mean 
difference 
(95% CI)
p-value
Baseline End of trial
Intervention MCPJ 71 (12) 69 (13) 3 (–10, 15) 0.6
PIPJ 58 (23) 57 (17) 1 (–13, 16) 0.8
DIPJ 48 (14) 47 (9) 1 (–12, 14) 0.9
Placebo MCPJ 68 (4) 72 (6) –4 (–9, 1) 0.1
PIPJ 74 (15) 77 (14) –2 (–8, 3) 0.3
DIPJ 62 (11) 62 (11) 0 (–7, 7) 0.9
Notes: Changes in measured aROM from baseline to the end of the trial (ie, over 
3 weeks) in the intervention and control groups. Changes compared by linear 
regression, with lossless nonparametric bootstrapping by resampling by replacement 
with 1,000 iterations.  
Abbreviations: aROM, active range of motion; CI, confidence interval; DIPJ, distal 
interphalangeal joint; MCPJ, metacarpophalangeal joint; PIPJ, proximal interphalangeal 
joint; SD, standard deviation.
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taping versus no taping, for symptomatic OA of finger joints. 
Thereafter, if an analgesic effect is observed, then kinesiology 
tape could be compared to other patterns of taping and other 
therapies (eg, splints, exercises, and medication, as taping is 
likely to consume fewer resources) and to determine whether 
it can delay surgery; all such studies should be conducted as 
randomized trials with concurrent economic analysis. 
Recruitment to clinical trials is difficult,20 and random-
ized trials in hand surgery are still uncommon. Therefore, an 
important learning point from this pilot trial is how clinicians 
can improve recruitment. Some explanations (and remedies) 
about why trials fail to recruit are well summarized21 and 
may have included 1) the absence of a dedicated researcher 
to oversee daily activities and 2) the lack of a supporting trial 
unit. Our trial was designed and run by full-time clinicians, 
and the surgeons are notoriously poor at recruiting patients 
to clinical trials.22 Therefore, we recommend that future 
trialists seek dedicated research staff to manage the trial. 
Furthermore, studies supported by trial units are more suc-
cessful,23 and so aspiring researchers should seek the support 
of a clinical trials unit. 
Limitations
At the outset, we did not know which method of taping was 
beneficial (if at all), and moreover, the absence of a true 
control (no tape) prevents exploration of the placebo effect. 
This is important because the placebo effect typically reduces 
OA pain with a pooled effect size of 0.51.24 As the mecha-
nism of action of kinesiology taping is not well understood, 
future researchers should randomize participants to a taping 
intervention compared to no intervention (ie, no taping).25 
Range of motion measurements are likely to be biased in 
favor of no difference because the therapist measuring the 
outcome and the participant both knew the digit was subject 
to experimentation, and we measured motion 1 week after 
removal of the tape, so any stiffness may have resolved. 
Whether the management of OA of the hand in secondary 
care is generalizable to the community is debatable. Our 
follow-up was very short, and hence, we are unable to com-
ment upon adherence to treatment, likelihood of adverse 
reactions, or long-term effectiveness. We did not specify a 
minimum clinically important difference (MCID) given the 
absence of data on hand OA; a reduction in OA pain of 4% 
is detectable using patient-reported outcome measures;26 
however, the recent network meta-analysis by da Costa 
et al27 concerning simple analgesia for OA pain suggested 
that the MCID effect size should be –0.37 (equating to a 
9 mm  difference on a 100 mm VAS). This is complimented 
by Singh’s work on OA pain which established the numerical 
(MCID) equivalent of “much better” as –33%, while –15% 
means “slightly better.”28 Therefore, our difference of 6% (6 
mm on a 100 mm VAS, equating to a Cohen’s effect size of 
–0.22) is unlikely to reach the accepted MCID. Furthermore, 
future researchers should consider the need for a minimum 
pain for entry, for example, to detect a MCID of –9 mm on 
a 100 mm VAS,27 the patients should have a baseline pain of 
at least 9 mm. We recommend that future trialists take stock 
of these limitations to improve their own studies.
Conclusion
We have shown that supportive tape on the dorsum of PIPJs 
affected by OA may reduce perceived pain. Whether this 
pain reduction is due to kinesiology taping or not requires 
further investigation.
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